Triamcinolone

Breastfeeding
  • TRADE NAMES: Aristocort; Aristospan (Sabex); Azmacort (Kos); Kenacort; Kenalog (Apothecon); Nasacort (Aventis); Triacet (Teva)
  • INDICATIONS: Arthralgias, asthma, dermatoses, inflammatory ocular conditions, rhinitis
  • CLASS: Corticosteroid, systemic, Corticosteroid, topical
  • HALF-LIFE: 17–25 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Acetazolamide, Adrenergic neurone blockers, Aldesleukin, Alpha blockers, Aminoglutethimide, Aminophylline, Amphotericin B, Angiotensin II receptor antagonists, Antacids, Antidiabetics, Antifungals, Aprepitant, Aspirin, Barbiturates, Beta blockers, Beta2 sympathomimetics, Calcium channel blockers, Calcium salts, Carbamazepine, Cardiac glycosides, Clonidine, Denosumab, Diazoxide, Diuretics, Erythromycin, Estrogens, Fluconazole, Fosaprepitant, Histamine, Hydralazine, Isoniazid, Itraconazole, Ketoconazole, Leflunomide, Leflunomide, Live vaccines, Loop diuretics, Macrolide antibiotics, Methyl salicylate, Methyldopa, Mifamurtide, Mifepristone, Minoxidil, Mitotane, Moxonidine, Natalizumab, Neuromuscular blocking agents, Nitrates, Nitroprusside, NSAIDs, Oral Contraceptives, Pancuronium, Phenindione, Phenobarbital, Phenytoin, Pimecrolimus, Primidone, Quinolones, Rifampin, Rifamycin derivatives, Salicylates, Sipuleucel-T, Sodium benzoate, Sodium phenylbutyrate, Somatropin, Tacrolimus, Thiazides, Vaccines, Vecuronium, Warfarin

PREGNANCY CATEGORY: C

Our database has 78 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of intravitreal triamcinolone in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 03/12/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top